312 related articles for article (PubMed ID: 36814224)
21. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
[TBL] [Abstract][Full Text] [Related]
22. Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma.
Hong X; Fu R
PLoS One; 2023; 18(12):e0295364. PubMed ID: 38039294
[TBL] [Abstract][Full Text] [Related]
23. Probing the Potential of Defense Response-Associated Genes for Predicting the Progression, Prognosis, and Immune Microenvironment of Osteosarcoma.
Huang L; Sun F; Liu Z; Jin W; Zhang Y; Chen J; Zhong C; Liang W; Peng H
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190333
[TBL] [Abstract][Full Text] [Related]
24. Identification and validation of long noncoding RNA AC083900.1 and RP11-283C24.1 for prediction of progression of osteosarcoma.
Huang L; Jin W; Bao Y; Zeng X; Zhang Y; Zhou J; Peng H
Mutat Res; 2023; 827():111828. PubMed ID: 37437507
[TBL] [Abstract][Full Text] [Related]
25. C-C Motif Chemokine Ligand 5 (CCL5): A Potential Biomarker and Immunotherapy Target for Osteosarcoma.
Zheng H; Wang Y; Li F
Curr Cancer Drug Targets; 2024; 24(3):308-318. PubMed ID: 37581517
[TBL] [Abstract][Full Text] [Related]
26. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma.
Xu F; Yan J; Peng Z; Liu J; Li Z
Front Immunol; 2022; 13():1096009. PubMed ID: 36618348
[TBL] [Abstract][Full Text] [Related]
28. A cuproptosis-related genes signature associated with prognosis and immune cell infiltration in osteosarcoma.
Yang W; Wu H; Tong L; Wang Y; Guo Q; Xu L; Yan H; Yin C; Sun Z
Front Oncol; 2022; 12():1015094. PubMed ID: 36276092
[TBL] [Abstract][Full Text] [Related]
29. Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma.
Zhang JS; Pan RS; Tian XB
Front Oncol; 2023; 13():1156663. PubMed ID: 37035149
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a pyroptosis-related prognostic signature associated with osteosarcoma metastasis and immune infiltration.
Gong Z; Wan Y; Han E; Zhou X; Huang J; Yu H; Shi Y; Lian K
Medicine (Baltimore); 2024 Apr; 103(14):e37642. PubMed ID: 38579086
[TBL] [Abstract][Full Text] [Related]
31. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
32. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
[No Abstract] [Full Text] [Related]
33. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
Liang X; Cheng Z; Chen X; Li J
Front Genet; 2022; 13():955424. PubMed ID: 36046241
[No Abstract] [Full Text] [Related]
34. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
35. Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature.
Zhong Y; Zhang Y; Wei S; Chen J; Zhong C; Cai W; Jin W; Peng H
Front Endocrinol (Lausanne); 2022; 13():1030655. PubMed ID: 36313783
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of endoplasmic reticulum stress-related eight-gene signature for predicting the overall survival of lung adenocarcinoma.
Lin L; Zhang W
Transl Cancer Res; 2022 Jul; 11(7):1909-1924. PubMed ID: 35966313
[TBL] [Abstract][Full Text] [Related]
37. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
38. Development and Validation of a Novel Gene Signature for Predicting the Prognosis of Idiopathic Pulmonary Fibrosis Based on Three Epithelial-Mesenchymal Transition and Immune-Related Genes.
Zheng J; Dong H; Zhang T; Ning J; Xu Y; Cai C
Front Genet; 2022; 13():865052. PubMed ID: 35559024
[No Abstract] [Full Text] [Related]
39. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients.
Wan Y; Qu N; Yang Y; Ma J; Li Z; Zhang Z
Bioengineered; 2021 Dec; 12(1):5916-5931. PubMed ID: 34488541
[TBL] [Abstract][Full Text] [Related]
40. Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction.
Zhu J; Yuan J; Arya S; Du Z; Liu X; Jia J
Front Immunol; 2023; 14():1265098. PubMed ID: 38169731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
